FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20191128E00229
1. Date of relevant event: 25/11/2019
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06855
4. Name of listed corporation: Ascentage Pharma Group International 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 208,901,727
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Tian
(Other names) Yuan
10. Name of director (Chinese): 田源 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
 
 		          
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position20,724,67610.00
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position20,724,6769.92
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position20,431,962
2101Beneficial owner
Long position292,714
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
28/10/202015/08/2028  HKD0.010  73,178
Long position
4105Unlisted derivatives - Physically settled
28/10/202115/08/2028  HKD0.010  73,178
Long position
4105Unlisted derivatives - Physically settled
28/10/202215/08/2028  HKD0.010  73,179
Long position
4105Unlisted derivatives - Physically settled
28/10/202315/08/2028  HKD0.010  73,179
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Shenzhen Qianhai Yuanming Asset Management Co., Ltd.Qianhai Complex A201, Qianwan Road 1, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen,P.R.ChinaTian Yuan90.00N
Long position1,271,790
Shenzhen Qianhai Yuanming Healthcare Fund (Limited Partnership)Qianhai Complex A201, Qianwan Road 1, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen,P.R.ChinaShenzhen Qianhai Yuanming Asset Management Co., Ltd.100.00N
Long position1,271,790
QHYM Investment LtdVistra Corporate Services Centre Wickhams Cay II Road Town Tortola VG1110 British Virgin IslandsShenzhen Qianhai Yuanming Healthcare Fund (Limited Partnership)100.00Y
Long position1,271,790
Zhuhai Hengqin Yuanming Asset Management Co., Ltd1576 Room 105, No.6 Baohua Road, Hengqin New District, Zhuhai, ChinaTian Yuan50.00N
Long position8,416,400
Zhuhai Hengqin Yuanming Private Equity (Limited Partnership)1859 Room 105, No.6 Baohua Road, Hengqin New District, Zhuhai, ChinaZhuhai Hengqin Yuanming Asset Management Co., Ltd100.00N
Long position8,416,400
YM Investment LtdOffshore Incorporations (Cayman) Limited Floor 4, Willow House Cricket Square P O Box 2804 Grand Cayman KY1-1112 Caymand IslandsZhuhai Hengqin Yuanming Private Equity (Limited Partnership)100.00Y
Long position8,416,400
Yuanming Capital Group LimitedSertus Incorporations (BVI) Limited, Sertus Chambers, P.O. BOX 905, Quastisky Building, Road Twon, Tortola, British Virgin IslandsTian Yuan100.00N
Long position10,743,772
Yuanming Capital Management LimitedSertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite #5-204, 23 Lime Tree Bay Avenue, P.O. BOX 2547, Grand Cayman, KY1-1104, Cayman IslandsYuanming Capital Group Limited50.00N
Long position10,743,772
Yuanming Prudence SPCOffice of Sertus Incorporations (Cayman) Limited, Sertus Chambers, Governors Square, Suite# 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KYl-1104, Cayman IslandsYuanming Capital Management Limited100.00Y
Long position10,743,772
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Tian Yuan holds his interest in box 28 through pre-IPO share options. The issued number of shares in the listed corporation has increased from 207,074,627 to 208,901,727 due to full exercise of the over-allotment option in respect of 1,827,100 shares.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 28/11/2019
(dd/mm/yyyy)